title: Heparin may be hard to beat: however much you are willing to spend on bivalirudin.
authors.affiliation: Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom. Electronic address: rod.stables@lhch.nhs.uk.
authors.forename: Rod H
authors.initials: RH
authors.lastname: Stables
mesh_terms: D000552:Ambulances; D000925:Anticoagulants / Q000008:administration & dosage*; D017023:Coronary Angiography; D003328:Coronary Thrombosis / Q000517:prevention & control*; D005260:Female; D006629:Hirudins / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D010446:Peptide Fragments / Q000008:administration & dosage*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects* / Q000295:instrumentation*; D015607:Stents
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments
keywords: acute myocardial infarction; anti-thrombotic therapy; primary percutaneous coronary intervention